Wake Up Wall Street (SPY) (QQQ): The dip that keeps on dipping

Get 50% off on Premium Subscribe to Premium

You have reached your limit of 5 free articles for this month.

Get Premium without limits for only $9.99 for the first month

Access all our articles, insights, and analysts.

coupon

Your coupon code

UNLOCK OFFER

Here is what you need to know on Wednesday, September 29:

A tumultuous Tuesday could lead to a Wednesday wipeout, but so for the portents of doom are being kept at bay as bargain hunters and bottom pickers enter the fray. Treasury yields are the new buzzword among investors, and these remain calm on Wednesday, leading to the potential for a dead cat bounce. Various Fed officials are on the wires this week with Fed chair Powell speaking at an ECB conference later today. Evergrande has taken a back seat but may reignite things as rumours circulate from Asia that it did not pay interest due on Wednesday. But China does appear to be acting as reports had circulated on Tuesday that it was asking state-owned enterprises to intervene. A bond default is not triggered for 30 days for most interest payments.

The US political scene still has the potential to sleepwalk markets into armageddon, that of a US debt default, as lawmakers argue over the debt ceiling and a government shutdown. That would make the current market malaise seem like a ripple in a tsunami of red. But really, this is a highly unlikely event.

The dollar remains impressed by higher yields at 1.1650 now versus the euro, while Oil is at $74.80 and Goldtrades at $1,743. Bitcoin is bouncing to $42,400 and the VIX is steady at 22.

See forex today

European markets are higher: EuroStoxx +0.8%, Dax +0.9% and FTSE +0.9%. 

US futures are also higher: S&P +0.3%, Dow +0.2% and Nasdaq +0.4%.

Wall Street (SPY) stock news

Amicus Therapeutics (FOLD) up 10% premarket as FDA accepts filings for Pompe treatment.

Eli Lilly (LLY) upgraded at Citi. 

Worthington Industries (WOR) up 7% on results.

Netflix (NFLX) is on the diversification game, as it announces it bought a video game maker.

Lucid (LCID) pops over 7% in premarket as CEO says production and delivery progressing with first deliveries due in October.

EQT Corp (EQT) down 6% on share offering.

Pfizer (PFE), Moderna (MRNA), BioNTech (BNTX): FDA said to mull over authorizing Moderna at half dose for booster shots-Bloomberg.

Affirm (AFRM) allows users to buy/sell crypto. Jefferies raises the price target.

Boeing (BA): Bernstein upgrades

Cal-Maine (CALM) up 4% premarket on higher than expected results.

Dollar Tree (DLTR) increases its share buyback plan.

 

Upgrades, downgrades and premarket movers

Source: Benzinga Pro

Economic releases

Here is what you need to know on Wednesday, September 29:

A tumultuous Tuesday could lead to a Wednesday wipeout, but so for the portents of doom are being kept at bay as bargain hunters and bottom pickers enter the fray. Treasury yields are the new buzzword among investors, and these remain calm on Wednesday, leading to the potential for a dead cat bounce. Various Fed officials are on the wires this week with Fed chair Powell speaking at an ECB conference later today. Evergrande has taken a back seat but may reignite things as rumours circulate from Asia that it did not pay interest due on Wednesday. But China does appear to be acting as reports had circulated on Tuesday that it was asking state-owned enterprises to intervene. A bond default is not triggered for 30 days for most interest payments.

The US political scene still has the potential to sleepwalk markets into armageddon, that of a US debt default, as lawmakers argue over the debt ceiling and a government shutdown. That would make the current market malaise seem like a ripple in a tsunami of red. But really, this is a highly unlikely event.

The dollar remains impressed by higher yields at 1.1650 now versus the euro, while Oil is at $74.80 and Goldtrades at $1,743. Bitcoin is bouncing to $42,400 and the VIX is steady at 22.

See forex today

European markets are higher: EuroStoxx +0.8%, Dax +0.9% and FTSE +0.9%. 

US futures are also higher: S&P +0.3%, Dow +0.2% and Nasdaq +0.4%.

Wall Street (SPY) stock news

Amicus Therapeutics (FOLD) up 10% premarket as FDA accepts filings for Pompe treatment.

Eli Lilly (LLY) upgraded at Citi. 

Worthington Industries (WOR) up 7% on results.

Netflix (NFLX) is on the diversification game, as it announces it bought a video game maker.

Lucid (LCID) pops over 7% in premarket as CEO says production and delivery progressing with first deliveries due in October.

EQT Corp (EQT) down 6% on share offering.

Pfizer (PFE), Moderna (MRNA), BioNTech (BNTX): FDA said to mull over authorizing Moderna at half dose for booster shots-Bloomberg.

Affirm (AFRM) allows users to buy/sell crypto. Jefferies raises the price target.

Boeing (BA): Bernstein upgrades

Cal-Maine (CALM) up 4% premarket on higher than expected results.

Dollar Tree (DLTR) increases its share buyback plan.

 

Upgrades, downgrades and premarket movers

Source: Benzinga Pro

Economic releases

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.